Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Deutsche Lufthansa AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Hesai Group to Report First Quarter 2026 Financial Results on Tuesday, May 19, 2026
-
BudPop Launches THC Gummies for Sex and Stress-Related Libido Support
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 24 04 2026] - (CGWL)
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 24 04 2026] - (CGAM)
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.3 - [ANIMALCARE GROUP PLC - 24 04 2026] - (CGWL)
-
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
-
Simply Contact Launches AI Call Simulation Onboarding Program for Multilingual Contact Center Agents
-
FTI Consulting Appoints Mike Davies to Capital Markets Practice
-
Tryg - Transactions in connection with share buyback programme
-
Danske Bank share buy-back programme: transactions in week 17
-
Zoomex Announces Today a Major Market Shift as $20.6 Trillion in Liquidity Moves Across Crypto Derivatives Platforms in 2026
-
27/2026・Trifork Group: Weekly report on share buyback
-
Transactions in connection with share buyback programme
-
Share buyback programme – week 17
-
Full Year Results for the year ended 31 December 2025
-
Global Power Solutions Signs Non-Binding LOI to Evaluate Development of Modular Hydrogen-Powered Energy Project
-
Veson and Veracity by DNV partner to streamline verified emissions reporting and commercial voyage management
-
Lumissil Introduces IS32LT3136 32-Channel Linear LED Driver for Next-Generation Automotive OLED Lighting
-
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
-
Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026
-
Prepayments, Realkredit Danmark A/S
-
Transparency Declaration Notification
-
Share repurchase programme: Transactions of week 17 2026
-
Notice of calling the annual general meeting of Hepsor AS
-
Preliminary data on early redemptions (prepayments)
-
Real-World Test of OMODA&JAECOO VPD: Mechanical Parking Spaces, Dead-End Roads, Mall Pickups – Can It Outperform an Experienced Driver?
-
Real-World Test of OMODA&JAECOO VPD: Mechanical Parking Spaces, Dead-End Roads, Mall Pickups – Can It Outperform an Experienced Driver?
-
Casino Group Communication
-
Garrett Motion’s Breakthrough Oil-Free Centrifugal Compressor Enhances High-Efficiency Liquid Cooling Solutions
-
Aspo Plc’s Interim Report, January 1 – March 31, 2026: Stable performance in a challenging operating environment
-
NBPE Announces Audited Annual Financial Report and 31 March 2026 monthly NAV
-
ASM announces resignation of Supervisory Board member Mr Van den Brink
-
Rob Shuter resigns from KPN’s Supervisory Board
-
NBPE Announces Transaction in Own Shares
-
Stablecoin Cross-border B2B Transactions to Reach $5 Trillion by 2035, Causing Disruption to Correspondent Banking Channels
-
Pulsar Helium Awards Security Based Compensation
-
WeRide and Lenovo Collaborate to Deploy 200,000 Autonomous Vehicles Globally Over Five Years
-
OMODA 4 Officially Rolls Off the Production Line: OMODA&JAECOO Embarks on a New Million Era
-
OMODA × VCT EMEA: Boundless Spirit, Esports Synergy – For Global Youth
-
FORVIA to Sell its Interiors Business Group to Apollo Funds
-
Apollo Funds to Acquire Forvia’s Automotive Interiors Business
-
Exosens delivers strong Q1 2026 performance, with accelerating defense momentum in digital imaging and night vision; Fully on track to deliver on 2026 guidance
-
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
-
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients

